SCHEMBL24310765

SCHEMBL24310765

CC(C)Oc1ncc(C(F)(F)F)cc1-c1cc(Oc2ccccc2)nc(N[S+]([O-])c2ccccc2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR39 O43194 1/20 0.38
▸ PTGS2 P35354 4/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ LMNA P02545 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ XBP1 P17861 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ BLM P54132 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP1A2 P05177 2/20 0.31
▸ CYP2C19 P33261 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ PTGES2 Q9H7Z7 1/20 0.31
▸ LIPE Q05469 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310764 0.82 SMN1; SMN2 (0.47) GPR39PTGS2SMN1; SMN2LMNAMAPT
SCHEMBL29566457 0.82 SMN1; SMN2 (0.47) GPR39PTGS2SMN1; SMN2LMNAMAPT
SCHEMBL24309476 0.72 GPR39 (0.41) GPR39SMN1; SMN2MAPTHTTMEN1
SCHEMBL26810941 0.71 LMNA (0.52) GPR39PTGS2SMN1; SMN2LMNAMAPT
SCHEMBL24309988 0.69 GPR39 (0.43) GPR39SMN1; SMN2LMNAMAPTHTT
SCHEMBL26811066 0.64 GPR39 (0.45) GPR39SMN1; SMN2LMNAMAPTHTT
SCHEMBL24309592 0.63 NPC1 (0.37) GPR39SMN1; SMN2LMNAMAPTHTT
SCHEMBL24309956 0.62 GPR39 (0.35) GPR39MAPTHTTMEN1KMT2A
SCHEMBL24310012 0.59 TSHR (0.46) GPR39SMN1; SMN2LMNAMAPTNPSR1
SCHEMBL29566878 0.59 TSHR (0.46) GPR39SMN1; SMN2LMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback